Glycated Albumin Guided Therapy in Newly Diagnosed Type 2 Diabetes A Randomized Controlled Trial.
Routine glycated albumin measurement could help doctors better adjust diabetes medications and track short-term blood sugar control.
Glycated albumin (GA) has already been introduced in clinic for decades. However, it remains unclear whether routine measurement of GA could serve as a practical tool to improve the care of patients with type 2 diabetes (T2DM).
What the study was
- Study design
- Randomized Controlled Trial
- Population
- Adult patients
- Sample size
- 200
- Category
- Other
- Maturity
- Potentially Practice-Changing
- Journal
- Journal of diabetes
Why it surfaced
Score 8/10: Randomized Controlled Trial, mixed model, Potentially Practice-Changing; flag=PROMISING_PRELIMINARY
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.